ARKF vs. AQST
ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK, while AQST (Aquestive Therapeutics, Inc.) is a stock. Over the past 5 years, ARKF returned -5.06%/yr vs -0.29%/yr for AQST. At a 0.34 correlation, their price movements are largely independent.
Performance
ARKF vs. AQST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKF achieves a -18.31% return, which is significantly higher than AQST's -35.45% return.
ARKF
- 1D
- 0.00%
- 1M
- -5.76%
- YTD
- -18.31%
- 6M
- -21.31%
- 1Y
- -11.87%
- 3Y*
- 23.97%
- 5Y*
- -5.06%
- 10Y*
- —
AQST
- 1D
- -0.95%
- 1M
- 0.97%
- YTD
- -35.45%
- 6M
- -32.85%
- 1Y
- 25.98%
- 3Y*
- 22.65%
- 5Y*
- -0.29%
- 10Y*
- —
ARKF vs. AQST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | -18.31% | 28.67% | 34.34% | 93.27% | -65.07% | -17.82% | 108.03% | 20.45% |
AQST Aquestive Therapeutics, Inc. | -35.45% | 81.46% | 76.24% | 123.92% | -76.81% | -27.29% | -8.08% | -3.64% |
Correlation
The correlation between ARKF and AQST is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2019 | 0.34 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKF vs. AQST — Risk / Return Rank
ARKF
AQST
ARKF vs. AQST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Fintech Innovation ETF (ARKF) and Aquestive Therapeutics, Inc. (AQST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKF | AQST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.66 | ||
| Sortino ratioReturn per unit of downside risk | -1.39 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.16 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.31 | 0.43 | -0.74 |
| Martin ratioReturn relative to average drawdown | -0.57 | 0.81 | -1.38 |
Loading charts...
Drawdowns
ARKF vs. AQST - Drawdown Comparison
The maximum ARKF drawdown since its inception was -78.63%, smaller than the maximum AQST drawdown of -96.68%. Use the drawdown chart below to compare losses from any high point for ARKF and AQST.
Loading charts...
Drawdown Indicators
| ARKF | AQST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.63% | -96.68% | +18.05% |
Max Drawdown (1Y)Largest decline over 1 year | -38.50% | -60.61% | +22.11% |
Max Drawdown (3Y)Largest decline over 3 years | -38.50% | -63.55% | +25.05% |
Max Drawdown (5Y)Largest decline over 5 years | -75.30% | -90.11% | +14.81% |
Current DrawdownCurrent decline from peak | -38.77% | -78.01% | +39.24% |
Average DrawdownAverage peak-to-trough decline | -34.95% | -76.92% | +41.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.00% | 32.01% | -11.01% |
Volatility
ARKF vs. AQST - Volatility Comparison
The current volatility for ARK Fintech Innovation ETF (ARKF) is 10.36%, while Aquestive Therapeutics, Inc. (AQST) has a volatility of 21.51%. This indicates that ARKF experiences smaller price fluctuations and is considered to be less risky than AQST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKF | AQST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.36% | 21.51% | -11.15% |
Volatility (6M)Calculated over the trailing 6-month period | 25.14% | 68.41% | -43.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.69% | 85.07% | -51.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.87% | 82.62% | -39.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.77% | 87.69% | -47.92% |
Dividends
ARKF vs. AQST - Dividend Comparison
ARKF's dividend yield for the trailing twelve months is around 0.11%, while AQST has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARKF ARK Fintech Innovation ETF | 0.11% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% |
Frequently Asked Questions
ARKF and AQST have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AQST has higher volatility (21.51%) compared to ARKF (10.36%). In terms of maximum drawdown, ARKF dropped -78.63% vs AQST's -96.68%.
AQST currently has the higher Sharpe Ratio (0.31 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKF and AQST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer